| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of PSAT1 mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | increases expression | ISO | RGD:1607031 | 6480464 | Estradiol results in increased expression of PSAT1 mRNA | CTD | PMID:15757668 PMID:20106945 |
| 17beta-estradiol | increases expression | ISO | RGD:1607031 | 6480464 | Estradiol results in increased expression of PSAT1 mRNA | CTD | PMID:20106945 PMID:15757668 |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of PSAT1 mRNA | CTD | PMID:17945193 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:735170 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PSAT1 mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1607031 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PSAT1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735170 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PSAT1 mRNA | CTD | PMID:20959002 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1607031 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PSAT1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PSAT1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735170 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PSAT1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735170 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PSAT1 mRNA | CTD | PMID:22298810 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:735170 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PSAT1 mRNA | CTD | PMID:20959002 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1607031 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PSAT1 mRNA | CTD | PMID:22079614 |
| acetylsalicylic acid | decreases expression | ISO | RGD:735170 | 6480464 | Aspirin results in decreased expression of PSAT1 mRNA | CTD | PMID:12800193 |
| aflatoxin B1 | affects expression | ISO | RGD:1607031 | 6480464 | Aflatoxin B1 affects the expression of PSAT1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of PSAT1 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1607031 | 6480464 | Tretinoin results in decreased expression of PSAT1 mRNA | CTD | PMID:16249480 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1607031 | 6480464 | Tretinoin results in decreased expression of PSAT1 mRNA | CTD | PMID:21934132 PMID:16249480 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1607031 | 6480464 | Tretinoin results in decreased expression of PSAT1 mRNA | CTD | PMID:16249480 PMID:21934132 |
| alpha-hexachlorocyclohexane | increases expression | ISO | RGD:735170 | 6480464 | alpha-hexachlorocyclohexane results in increased expression of PSAT1 mRNA | CTD | PMID:17785943 |
| ammonium chloride | affects expression | ISO | RGD:735170 | 6480464 | Ammonium Chloride affects the expression of PSAT1 mRNA | CTD | PMID:16483693 |
| arachidonic acid | increases expression | ISO | RGD:1607031 | 6480464 | Arachidonic Acid results in increased expression of PSAT1 mRNA | CTD | PMID:16704987 |
| benzo[a]pyrene | increases expression | ISO | RGD:1607031 | 6480464 | Benzo(a)pyrene results in increased expression of PSAT1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PSAT1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PSAT1 mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PSAT1 mRNA | CTD | PMID:21715664 |
| bisphenol A | decreases expression | ISO | RGD:1607031 | 6480464 | bisphenol A results in decreased expression of PSAT1 mRNA | CTD | PMID:20678512 |
| butyric acid | decreases expression | ISO | RGD:735170 | 6480464 | Butyric Acid results in decreased expression of PSAT1 mRNA | CTD | PMID:12800193 |
| chloroethene | increases expression | EXP | | 6480464 | Vinyl Chloride results in increased expression of PSAT1 mRNA | CTD | PMID:18579281 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PSAT1 mRNA | CTD | PMID:20938992 |
| cisplatin | decreases expression | ISO | RGD:735170 | 6480464 | Cisplatin results in decreased expression of PSAT1 mRNA | CTD | PMID:22023808 |
| clofibric acid | multiple interactions | ISO | RGD:735170 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PSAT1 mRNA | CTD | PMID:17602206 |
| cobalt atom | multiple interactions | ISO | RGD:1607031 | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of PSAT1 mRNA | CTD | PMID:18078969 |
| cobalt atom | multiple interactions | ISO | RGD:1607031 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of PSAT1 mRNA | CTD | PMID:23052192 |
| cobalt dichloride | decreases expression | ISO | RGD:1607031 | 6480464 | cobaltous chloride results in decreased expression of PSAT1 mRNA | CTD | PMID:19376846 |
| copper(2+) sulfate | increases expression | ISO | RGD:1607031 | 6480464 | Copper Sulfate results in increased expression of PSAT1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | ISO | RGD:1607031 | 6480464 | Cyclosporine results in increased expression of PSAT1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1607031 | 6480464 | Cyclosporine results in increased expression of PSAT1 mRNA | CTD | PMID:20106945 PMID:22147139 |
| cyclosporin A | increases expression | ISO | RGD:1607031 | 6480464 | Cyclosporine results in increased expression of PSAT1 mRNA | CTD | PMID:20106945 more ... |
| dasatinib (anhydrous) | increases expression | ISO | RGD:1607031 | 6480464 | dasatinib results in increased expression of PSAT1 mRNA | CTD | PMID:20579391 |
| dexamethasone | decreases expression | ISO | RGD:735170 | 6480464 | Dexamethasone results in decreased expression of PSAT1 mRNA | CTD | PMID:20032058 |
| dexamethasone | multiple interactions | ISO | RGD:735170 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PSAT1 mRNA] | CTD | PMID:20032058 |
| diarsenic trioxide | decreases expression | ISO | RGD:1607031 | 6480464 | arsenic trioxide results in decreased expression of PSAT1 mRNA | CTD | PMID:19128835 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of PSAT1 mRNA | CTD | PMID:21266533 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PSAT1 mRNA | CTD | PMID:19167417 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PSAT1 mRNA | CTD | PMID:20938992 |
| genistein | increases expression | ISO | RGD:1607031 | 6480464 | Genistein results in increased expression of PSAT1 mRNA | CTD | PMID:15757668 |
| hydrazine | increases expression | EXP | | 6480464 | hydrazine results in increased expression of PSAT1 mRNA | CTD | PMID:15282401 |
| indole-3-methanol | affects expression | ISO | RGD:735170 | 6480464 | indole-3-carbinol affects the expression of PSAT1 mRNA | CTD | PMID:21396975 |
| indole-3-methanol | multiple interactions | ISO | RGD:735170 | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSAT1 mRNA]; more ... | CTD | PMID:22129741 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PSAT1 mRNA | CTD | PMID:20938992 |
| lamivudine | multiple interactions | ISO | RGD:1607031 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA | CTD | PMID:15784690 |
| lucanthone | decreases expression | ISO | RGD:1607031 | 6480464 | Lucanthone results in decreased expression of PSAT1 mRNA | CTD | PMID:21148553 |
| menadione | affects expression | ISO | RGD:1607031 | 6480464 | Vitamin K 3 affects the expression of PSAT1 mRNA | CTD | PMID:20044591 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:735170 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA; more ... | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:735170 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PSAT1 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:735170 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA; more ... | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:735170 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PSAT1 mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:735170 | 6480464 | Diethylnitrosamine results in increased expression of PSAT1 mRNA | CTD | PMID:19638242 |
| nickel dichloride | increases expression | ISO | RGD:1607031 | 6480464 | nickel chloride results in increased expression of PSAT1 mRNA | CTD | PMID:17312168 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of PSAT1 mRNA | CTD | PMID:17095637 |
| ozone | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Ozone results in increased expression of PSAT1 mRNA] | CTD | PMID:17460151 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of PSAT1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1607031 | 6480464 | Acetaminophen results in increased expression of PSAT1 mRNA | CTD | PMID:21420995 |
| paracetamol | decreases expression | ISO | RGD:735170 | 6480464 | Acetaminophen results in decreased expression of PSAT1 mRNA | CTD | PMID:18246545 |
| perfluorooctanoic acid | increases expression | ISO | RGD:735170 | 6480464 | perfluorooctanoic acid results in increased expression of PSAT1 mRNA | CTD | PMID:19162173 |
| phorone | affects expression | ISO | RGD:735170 | 6480464 | phorone affects the expression of PSAT1 mRNA | CTD | PMID:18198479 |
| pirinixic acid | multiple interactions | ISO | RGD:1607031 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PSAT1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:735170 | 6480464 | pirinixic acid results in increased expression of PSAT1 mRNA | CTD | PMID:17164430 PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:735170 | 6480464 | pirinixic acid results in increased expression of PSAT1 mRNA | CTD | PMID:19162173 PMID:17164430 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PSAT1 mRNA | CTD | PMID:18301758 |
| piroxicam | decreases expression | ISO | RGD:1607031 | 6480464 | Piroxicam results in decreased expression of PSAT1 mRNA | CTD | PMID:21858171 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:735170 | 6480464 | Pregnenolone Carbonitrile results in increased expression of PSAT1 mRNA | CTD | PMID:19162173 |
| progesterone | increases expression | ISO | RGD:1607031 | 6480464 | Progesterone results in increased expression of PSAT1 mRNA | CTD | PMID:18037150 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of PSAT1 mRNA | CTD | PMID:21278054 |
| prostaglandin A1 | increases metabolic processing | EXP | | 6480464 | prostaglandin A1 analog results in increased metabolism of PSAT1 protein | CTD | PMID:19800325 |
| quercetin | decreases expression | ISO | RGD:1607031 | 6480464 | Quercetin results in decreased expression of PSAT1 mRNA | CTD | PMID:21632981 |
| rosiglitazone | increases expression | ISO | RGD:735170 | 6480464 | rosiglitazone results in increased expression of PSAT1 mRNA | CTD | PMID:21515302 |
| testosterone | multiple interactions | ISO | RGD:735170 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PSAT1 mRNA] | CTD | PMID:20032058 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of PSAT1 mRNA | CTD | PMID:19042947 |
| zidovudine | multiple interactions | ISO | RGD:1607031 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA | CTD | PMID:15784690 |
| zinc atom | increases expression | ISO | RGD:735170 | 6480464 | Zinc deficiency results in increased expression of PSAT1 mRNA | CTD | PMID:16140947 |
| zinc atom | multiple interactions | ISO | RGD:735170 | 6480464 | Zinc inhibits the reaction [Zinc deficiency results in increased expression of PSAT1 mRNA] | CTD | PMID:16140947 |
| zinc(0) | increases expression | ISO | RGD:735170 | 6480464 | Zinc deficiency results in increased expression of PSAT1 mRNA | CTD | PMID:16140947 |
| zinc(0) | multiple interactions | ISO | RGD:735170 | 6480464 | Zinc inhibits the reaction [Zinc deficiency results in increased expression of PSAT1 mRNA] | CTD | PMID:16140947 |